Jan 24 (Reuters) - Qianjiang Yongan Pharmaceutical Co Ltd
* Says a Shenzhen-based capital management firm cut stake in the co to 6.6 percent(13 million shares) from 11.2 percent (21.9 million shares), during the period from Aug. 4, 2017 to Jan. 18, 2018
Source text in Chinese: goo.gl/VgA2ay
Further company coverage: (Beijing Headline News)
 